This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gray, R. S. Articles by Howard, B. V. Search for Related Content PubMed PubMed Citation Articles by Gray, R. S. Articles by Howard, B. V.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2713-2720.)
© 1997 American Heart Association, Inc.

Articles

Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians

The Strong Heart Study

R. Stuart Gray; David C. Robbins; Wenyu Wang; Jeunliang L. Yeh; Richard R. Fabsitz; Linda D. Cowan; Thomas K. Welty; Elisa T. Lee; Ronald M. Krauss; ; Barbara V. Howard

From the Medlantic Research Institute, Washington, DC (B.V.H., D.C.R., R.S.G.); the Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City (L.D.C., E.T.L.); the Center for Epidemiologic Research, Oklahoma City, Okla (J.L.Y., W.W.); the National Heart, Lung, and Blood Institute, Bethesda, Md (R.R.F.); and the Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, Calif (R.M.K.).

Abstract Small, dense LDL has been shown to be associated with the insulin resistance syndrome and coronary heart disease (CHD). We examined the distribution of LDL size and phenotype within a population-based sample of American Indians to determine the relationships with prevalent CHD and to examine associations with hyperinsulinemia and other components of the insulin resistance syndrome. Data were available for 4505 men and women between 45 and 74 years of age who are members of 13 American Indian communities in three geographic areas. Diabetes, CHD, and CHD risk factors were assessed by standardized techniques, and LDL size was measured by gradient gel electrophoresis. LDL size was smaller in men than in women and in individuals with diabetes than in those without diabetes. In multivariate analysis, LDL size was significantly related to several components of the insulin resistance syndrome, including triglycerides (inversely) and HDL cholesterol (positively). Although univariate relations were positive, LDL size was not significantly related to fasting insulin concentrations or body mass index in the multivariate model. LDL size also showed no relationship to apolipoprotein E phenotype. When LDL size was compared in individuals with and without CHD, no significant differences were observed, either in nondiabetic or diabetic individuals. We conclude that LDL size is most strongly related to lipoprotein components of the insulin resistance syndrome, especially plasma triglycerides. However, in this population with low LDL, it is not related to cardiovascular disease.

Key Words: American Indians • LDL size • coronary heart disease • diabetes mellitus, • Strong Heart Study

This article has been cited by other articles:

				H.-h. Chen, B. D. Hosken, M. Huang, J. W. Gaubatz, C. L. Myers, R. D. Macfarlane, H. J. Pownall, and C.-y. Yang Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic J. Lipid Res., January 1, 2007; 48(1): 177 - 184. [Abstract] [Full Text] [PDF]

				B. V. Howard, L. G. Best, J. M. Galloway, W. J. Howard, K. Jones, E. T. Lee, R. E. Ratner, H. E. Resnick, and R. B. Devereux Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors Diabetes Care, February 1, 2006; 29(2): 391 - 397. [Abstract] [Full Text] [PDF]

				H. N. Ginsberg REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392. [Abstract] [Full Text] [PDF]

				M. Rizzo and K. Berneis Low-density lipoprotein size and cardiovascular risk assessment QJM, January 1, 2006; 99(1): 1 - 14. [Abstract] [Full Text] [PDF]

				D. S. Freedman, J. D. Otvos, E. J. Jeyarajah, I. Shalaurova, L. A. Cupples, H. Parise, R. B. D'Agostino, P. W.F. Wilson, and E. J. Schaefer Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study Clin. Chem., July 1, 2004; 50(7): 1189 - 1200. [Abstract] [Full Text] [PDF]

				Y. Bosse, L. Perusse, and M.-C. Vohl Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026. [Abstract] [Full Text] [PDF]

				F. M. Sacks and H. Campos Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4525 - 4532. [Full Text] [PDF]

				K. Winkler, T. Konrad, S. Fullert, I. Friedrich, R. Destani, M. W. Baumstark, K. Krebs, H. Wieland, and W. Marz Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension: A double-blind, placebo-controlled study Diabetes Care, September 1, 2003; 26(9): 2588 - 2594. [Abstract] [Full Text] [PDF]

				P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men Arterioscler Thromb Vasc Biol, February 14, 2003; 23(2): 314 - 321. [Abstract] [Full Text] [PDF]

				H. Campos, L. A. Moye, S. P. Glasser, M. J. Stampfer, and F. M. Sacks Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events JAMA, September 26, 2001; 286(12): 1468 - 1474. [Abstract] [Full Text] [PDF]

				W. Marz, H. Scharnagl, C. Abletshauser, M. M. Hoffmann, A. Berg, J. Keul, H. Wieland, and M. W. Baumstark Fluvastatin Lowers Atherogenic Dense Low-Density Lipoproteins in Postmenopausal Women With the Atherogenic Lipoprotein Phenotype Circulation, April 17, 2001; 103(15): 1942 - 1948. [Abstract] [Full Text] [PDF]

				J. Hulthe, L. Bokemark, J. Wikstrand, and B. Fagerberg The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis : The Atherosclerosis and Insulin Resistance (AIR) Study Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2140 - 2147. [Abstract] [Full Text] [PDF]

				L. Mykkanen, J. Kuusisto, S. M. Haffner, M. Laakso, and M. A. Austin LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2742 - 2748. [Abstract] [Full Text] [PDF]

				R. V. Shohet, G. L. Vega, A. Anwar, J. E. Cigarroa, S. M. Grundy, and J. C. Cohen Hepatic Lipase (LIPC) Promoter Polymorphism in Men With Coronary Artery Disease : Allele Frequency and Effects on Hepatic Lipase Activity and Plasma HDL-C Concentrations Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1975 - 1978. [Abstract] [Full Text] [PDF]

				B. V. Howard, E. T. Lee, L. D. Cowan, R. B. Devereux, J. M. Galloway, O. T. Go, W. J. Howard, E. R. Rhoades, D. C. Robbins, M. L. Sievers, et al. Rising Tide of Cardiovascular Disease in American Indians : The Strong Heart Study Circulation, May 11, 1999; 99(18): 2389 - 2395. [Abstract] [Full Text] [PDF]